Skip to main content
Premium Trial:

Request an Annual Quote

Sequencing Companies Serving Niche Markets

Discussions of Dan Koboldt's recent blog post outlining "Next-Gen Sequencing in 2010," are reverberating throughout the blogosphere: BNET picked up his post and Daniel MacArthur has contributed his thoughts on the state of sequencing technologies, post-AGBT meeting. Kobolt suggests that, in stark contrast to the disposition of the sequencing powerhouses in 2009 ― "every player was gunning to take over the world" ― companies now appear to have "a niche in mind." In the "general sequencing" category, Koboldt writes, it remains Illumina versus Life Technologies. Roche/454 platforms cater to researchers seeking long-read sequencing runs, while Complete Genomics is still the frontrunner in "sequencing as a service." This year's debut of the Ion Torrent sequencing machine introduces what Koboldt calls "sequencing for the masses," while Pacific Biosciences and Oxford Nanopore are focusing on targeted applications.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.